Skip to main content
Clinical Trials/CTRI/2023/05/052301
CTRI/2023/05/052301Not yet recruitingPhase 2

Randomized clinical study to evaluate the efficacy of Shuddh Shilajit and Maansyadi Kashaya in the management of Aavrit Vyan w.s.r. to Essential Hypertension

Ayurvedic and Unani Tibbia College and Hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Subject willing to participate and able to provide written informed consent.
  • 2. Patient diagnosed as stage-I Essential Hypertension would be selected for study on the basis of 8th JNC & WHO criteria.
  • 3. Subjects who are able to come for follow up on fixed visits.

Exclusion Criteria

  • 1. Already diagnosed cases of Cardiovascular disease/ Cerebrovascular disease/ Renal disease/ Hypertensive Retinopathy.
  • 2. Subjects with any unstable heart disease or known cases of MI, unstable angina or CHF.
  • 3. Patients with concurrent hepatic dysfunction (defined as AST and/or ALT >2times of the upper normal limit) or Renal dysfunction, uncontrolled pulmonary dysfunction (asthmatic and COPD subjects).
  • 4. Subjects with current or past malignancy.
  • 5. Subject of have recent history or who are currently known to abuse of alcohol or drugs.
  • 6. Subjects suffering from major systemic illness neccessitating long term drug treatment(rheumatoid arthritis, psyco-neuro-endocrinal disorders, Tb, AIDS).
  • 7. Pregnant/lactating women.
  • 8. Subject on systemic or local steroids, oral contraceptive pills or estrogen replacement therapy.
  • 9. Subjects having hypersensitivity to any of the trial drug.
  • 10. Subjects who have completed participation in any other clinical trial during the past six (06) months.

Investigators

Sponsor
Ayurvedic and Unani Tibbia College and Hospital

Similar Trials